| Literature DB >> 25954173 |
Alberto J López1, Marcelo A Wood1.
Abstract
It is becoming increasingly important to understand how epigenetic mechanisms control gene expression during neurodevelopment. Two epigenetic mechanisms that have received considerable attention are DNA methylation and histone acetylation. Human exome sequencing and genome-wide association studies have linked several neurobiological disorders to genes whose products actively regulate DNA methylation and histone acetylation. More recently, a third major epigenetic mechanism, nucleosome remodeling, has been implicated in human developmental and intellectual disability (ID) disorders. Nucleosome remodeling is driven primarily through nucleosome remodeling complexes with specialized ATP-dependent enzymes. These enzymes directly interact with DNA or chromatin structure, as well as histone subunits, to restructure the shape and organization of nucleosome positioning to ultimately regulate gene expression. Of particular interest is the neuron-specific Brg1/hBrm Associated Factor (nBAF) complex. Mutations in nBAF subunit genes have so far been linked to Coffin-Siris syndrome (CSS), Nicolaides-Baraitser syndrome (NBS), schizophrenia, and Autism Spectrum Disorder (ASD). Together, these human developmental and ID disorders are powerful examples of the impact of epigenetic modulation on gene expression. This review focuses on the new and emerging role of nucleosome remodeling in neurodevelopmental and ID disorders and whether nucleosome remodeling affects gene expression required for cognition independently of its role in regulating gene expression required for development.Entities:
Keywords: BAF53b; autism spectrum disorders (ASD); coffin-siris syndrome; epigenetics; intellectual disability; nicolaides-baraitser syndrome; nucleosome remodeling; rubinstein-taybi syndrome
Year: 2015 PMID: 25954173 PMCID: PMC4407585 DOI: 10.3389/fnbeh.2015.00100
Source DB: PubMed Journal: Front Behav Neurosci ISSN: 1662-5153 Impact factor: 3.558
BAF subunit coding genes implicated in neurological disorders.
| SWI1 | ARID1A | css | Staahl and Crabtree, | |
| ARID1B | CSS, NBS, ID, ASD | Backx et al., | ||
| SWI2, ISNF2 | SMARCA2 | NBS, SZ | Koga et al., | |
| SMARCA4 | css | Tsurusaki et al., | ||
| SMARCB1 | NBS, CSS, ID | Santen et al., | ||
| SWI3 | SMARCC1 | ASD | Neale et al., | |
| SMARCC2 | ASD | Neale et al., | ||
| SMARCE1 | css | Tsurusaki et al., | ||
| CREST | sz | Chesi et al., |
Adapted from and Staahl and Crabtree (.
Figure 1Proposed model of the nBAF complex. Subunits in white are subunits thought to be neuron-specific. Adapted from Staahl and Crabtree (2013).
Figure 2Exploded view of nBAF complex. Mammalian subunits associated with neuro developmental and/or cognitive disorders are in blue. Human gene name is also included below subunit name. Mammalian subunits in gray have no currently known mutations linked with new:odevelopment or adult cognition.